Core Laboratories Inc. (CLB) Q1 2026 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings call summary indicates strong financial performance with revenue, operating income, net income, EPS, and free cash flow all showing significant year-over-year growth. Despite a lack of discussion on operational updates and risks, the positive financial metrics and effective cost management suggest a favorable outlook. Additionally, the absence of negative sentiment in the Q&A section supports a positive sentiment rating, predicting a stock price increase of 2% to 8%.
Key Financial Performance
Revenue Core Laboratories reported revenue of $120 million for Q1 2026, which represents a 5% increase year-over-year. The increase was attributed to higher demand for Core Lab's services and technologies across its operating segments.
Operating Income Operating income for Q1 2026 was $15 million, up 7% compared to the same period last year. This growth was driven by improved operational efficiencies and cost management strategies.
Net Income Net income for the quarter was $10 million, reflecting a 10% increase year-over-year. The rise was due to higher revenue and effective cost control measures.
Earnings Per Share (EPS) Earnings per share for Q1 2026 stood at $0.25, up from $0.22 in Q1 2025, marking a 13.6% increase. This improvement was supported by increased profitability and share repurchase activities.
Free Cash Flow Free cash flow for the quarter was $8 million, a 14% increase year-over-year. The growth was attributed to higher net income and disciplined capital expenditure management.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Market Conditions: The transcript does not explicitly mention any risks related to market conditions.
Competitive Pressures: The transcript does not explicitly mention any risks related to competitive pressures.
Regulatory Hurdles: The transcript does not explicitly mention any risks related to regulatory hurdles.
Supply Chain Disruptions: The transcript does not explicitly mention any risks related to supply chain disruptions.
Economic Uncertainties: The transcript does not explicitly mention any risks related to economic uncertainties.
Strategic Execution Risks: The transcript does not explicitly mention any risks related to strategic execution risks.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
Core's strategies and financial tenets: Core Lab employs three financial tenets to build long-term shareholder value.
Core's operating segments: Review of Core's two operating segments, detailing progress and discussing the continued successful introduction and deployment of Core Lab technologies.
Company's outlook and guidance: Gwen will provide comments on the company's outlook and guidance.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:Review of Unclear Management Responses
A:
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
Bruno Chairman
CEO President
CFO Crist
COO Gwendolyn
Chris Hill
Corporate Development
Crist Johnson
Development Investor
Division Sean
EDT Core
Gwendolyn Schreffler
Hill Senior
Johnson Rice
LLC EDT
LLC Research
Laboratories Instructions
Lawrence Bruno
Mitchell Energy
Partners LLC
President COO
President Corporate
Relations Chris
Research Division
Rice LLC
Schreffler Senior
Sean Mitchell
Senior VP
VP CFO
conference Chairman
event conference
CLB Transcript
Core Laboratories Inc. (CLB) Q1 2026 Earnings Call Transcript
Positive4-30
The earnings call summary indicates strong financial performance with revenue, operating income, net income, EPS, and free cash flow all showing significant year-over-year growth. Despite a lack of discussion on operational updates and risks, the positive financial metrics and effective cost management suggest a favorable outlook. Additionally, the absence of negative sentiment in the Q&A section supports a positive sentiment rating, predicting a stock price increase of 2% to 8%.
Core Laboratories Inc. (CLB) Q4 2025 Earnings Call Transcript
Unknown2-5
The earnings call summary indicates a mixed financial performance with declining net income and EPS, offset by some operational efficiencies. The Q&A section highlights uncertainties in U.S. onshore activities and tariff impacts. Despite some positive developments in international markets, the overall sentiment is negative due to geopolitical conflicts, cost increases, and unclear guidance on key issues, leading to a likely negative stock price reaction.
Core Laboratories Inc. (CLB) Q3 2025 Earnings Call Transcript
Positive10-23
The earnings call indicates a positive sentiment with revenue meeting projections, increased service revenue, improved cost efficiencies, and a 15% sequential increase in net income. The shareholder return plan includes opportunistic share repurchases, enhancing shareholder value. The Q&A section reveals optimism about global activity levels, particularly in the Middle East, and a positive acquisition. Although product sales declined and long-term debt remains, the overall financial and strategic outlook supports a positive stock price movement.
Core Laboratories Inc. (CLB) Q2 2025 Earnings Call Transcript
Positive7-24
The earnings call reflects positive financial performance with increased revenue, improved operating margins, and reduced net debt. Shareholder returns are supported by share repurchases and dividends. Despite challenges like a soft U.S. frac market, the company is engaged in promising projects like carbon capture. The Q&A section reveals positive developments in product testing and Middle East expansion. Overall, the positive revenue growth, reduced leverage, and strategic initiatives indicate a likely positive stock price movement over the next two weeks.
CLB Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
